Literature DB >> 17697527

Predictive models for post-operative nausea and vomiting in patients using patient-controlled analgesia.

Y Y Lee1, K H Kim, Y H Yom.   

Abstract

This study identified predictive factors for post-operative nausea and vomiting (PONV) in patients using patient-controlled analgesia (PCA) and developed five predictive model pathways to calculate the probability of PONV using decision tree analysis. The sample consisted of 1181 patients using PCA. Data were collected using: a specifically designed check-off form to collect patient-, surgery-, anaesthesia- and post-operation-related data; the Beck Anxiety Inventory to measure pre-operative anxiety; and a visual analogue scale, to measure post-operative pain. The incidence of PONV was 27.7%. Nine factors were highly predictive of PONV in our five model pathways: gender, obesity, anxiety, history of previous PONV, history of motion sickness, inhalation of nitrous oxide during operation, use of inhalational agents, starting oral fluid/food intake after operation, and post-operative pain. With these five predictive model pathways, we can predict the probability of PONV in an individual patient according to their individual characteristics.

Entities:  

Mesh:

Year:  2007        PMID: 17697527     DOI: 10.1177/147323000703500409

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  7 in total

1.  Static and dynamic autonomic response with increasing nausea perception.

Authors:  Lauren T LaCount; Riccardo Barbieri; Kyungmo Park; Jieun Kim; Emery N Brown; Braden Kuo; Vitaly Napadow
Journal:  Aviat Space Environ Med       Date:  2011-04

2.  Comparison of the incidence of postoperative nausea and vomiting between women undergoing open or robot-assisted thyroidectomy.

Authors:  Ji Young Yoo; Yun Jeong Chae; Han Bum Cho; Kyu Hyun Park; Jin Su Kim; Sook Young Lee
Journal:  Surg Endosc       Date:  2012-12-13       Impact factor: 4.584

3.  Aversive and reinforcing opioid effects: a pharmacogenomic twin study.

Authors:  Martin S Angst; Laura C Lazzeroni; Nicholas G Phillips; David R Drover; Martha Tingle; Amrita Ray; Gary E Swan; J David Clark
Journal:  Anesthesiology       Date:  2012-07       Impact factor: 7.892

4.  Opioid-receptor antagonism increases pain and decreases pleasure in obese and non-obese individuals.

Authors:  Rebecca C Price; Nicolas V Christou; Steven B Backman; Laura Stone; Petra Schweinhardt
Journal:  Psychopharmacology (Berl)       Date:  2016-09-22       Impact factor: 4.530

Review 5.  Pharmacology of morphine in obese patients: clinical implications.

Authors:  Célia Lloret Linares; Xavier Declèves; Jean Michel Oppert; Arnaud Basdevant; Karine Clement; Christophe Bardin; Jean Michel Scherrmann; Jean Pierre Lepine; Jean François Bergmann; Stéphane Mouly
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

6.  Anti-emetic Action of the Brain-Penetrating New Ghrelin Agonist, HM01, Alone and in Combination With the 5-HT3 Antagonist, Palonosetron and With the NK1 Antagonist, Netupitant, Against Cisplatin- and Motion-Induced Emesis in Suncus murinus (House Musk Shrew).

Authors:  John A Rudd; Sze W Chan; Man P Ngan; Longlong Tu; Zengbing Lu; Claudio Giuliano; Emanuela Lovati; Claudio Pietra
Journal:  Front Pharmacol       Date:  2018-08-06       Impact factor: 5.810

7.  Orthostatic intolerance ambulation in patients using patient controlled analgesia.

Authors:  Kwang Ok Park; Yoon Young Lee
Journal:  Korean J Pain       Date:  2013-07-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.